The rates of decline of genital gonococcal and chlamydial infections worldwide are encouraging. Recent developments in laboratory diagnostic and screening methods, oral single-dose therapy and new knowledge of the immunobiology of these pathogens offer the promise of a vaccine and opportunities to design innovative strategies for their control and ultimate eradication.